ERn Financial LLC Invests $3.18 Million in Axon Enterprise, Inc. (NASDAQ:AXON)

ERn Financial LLC purchased a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 5,352 shares of the biotechnology company's stock, valued at approximately $3,181,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Insigneo Advisory Services LLC boosted its stake in Axon Enterprise by 1.4% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock worth $627,000 after purchasing an additional 22 shares during the last quarter. Menard Financial Group LLC boosted its position in Axon Enterprise by 0.8% during the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock worth $1,204,000 after acquiring an additional 24 shares during the last quarter. PFG Investments LLC grew its stake in Axon Enterprise by 0.6% during the 3rd quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company's stock valued at $1,547,000 after acquiring an additional 25 shares in the last quarter. Gladstone Institutional Advisory LLC raised its holdings in Axon Enterprise by 1.6% in the 3rd quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company's stock valued at $656,000 after acquiring an additional 26 shares during the last quarter. Finally, Mather Group LLC. lifted its stake in Axon Enterprise by 3.7% in the 3rd quarter. Mather Group LLC. now owns 759 shares of the biotechnology company's stock worth $303,000 after purchasing an additional 27 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on AXON. JMP Securities upped their price target on Axon Enterprise from $430.00 to $500.00 and gave the company a "market outperform" rating in a research report on Thursday, October 31st. TD Cowen started coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 target price for the company. Needham & Company LLC raised their target price on Axon Enterprise from $525.00 to $600.00 and gave the stock a "buy" rating in a research note on Friday, November 8th. Morgan Stanley raised shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and boosted their price target for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a "buy" rating in a research report on Wednesday, October 23rd. One investment analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $504.92.

Insider Buying and Selling

In related news, insider Jeffrey C. Kunins sold 21,834 shares of the company's stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the sale, the insider now directly owns 154,394 shares of the company's stock, valued at $91,691,508.72. This represents a 12.39 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the firm's stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the transaction, the director now directly owns 2,392 shares of the company's stock, valued at $1,631,487.52. This represents a 34.52 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 50,545 shares of company stock valued at $30,721,337. Corporate insiders own 5.70% of the company's stock.

Axon Enterprise Trading Up 0.0 %

AXON opened at $580.00 on Thursday. Axon Enterprise, Inc. has a 52 week low of $246.99 and a 52 week high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The business has a fifty day simple moving average of $612.80 and a 200-day simple moving average of $454.94. The firm has a market cap of $44.23 billion, a P/E ratio of 149.87, a P/E/G ratio of 5.71 and a beta of 1.04.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.